Jan 22 (Reuters) - Corcept Therapeutics said on Thursday a late-stage trial showed its experimental drug in combination with chemotherapy helped reduce the risk of death in patients with a type of ...
Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide ...
Right after a heart attack, the risk of having another one is very high. This is the most dangerous time for your heart. Blood vessels are still fragile and more likely to form dangerous clots. That’s ...
Epcoritamab combo reduced the risk of disease progression or death by 79% in the Phase 3 FL trial. Genmab raised its 2025 revenue outlook to $3.5–$3.7 billion after Q2 beat and 19% Y/Y growth. Up Next ...
While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) ...
Cogent will submit the PEAK New Drug Application (NDA) under previously announced RTOR designation; on track to complete NDA submission in ...
A combination of two cancer drugs significantly boosts lifespan in mice, according to a new study that may lead to better strategies for longevity. The drugs rapamycin and trametinib given together as ...
News Medical on MSN
Combination therapy improves cognition in Alzheimer’s models
In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...
Polysubstance use has become a defining feature of the U.S. overdose crisis in the past decade. While not every overdose involves multiple substances, a significant and growing proportion includes ...
Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one-third of the adult population. This disorder is characterized by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results